THERIVA
Dead / Abandoned — Abandoned — no statement of use filed (as of 30 Mar 2026)
What this means for you
This application is over — abandoned 30 Mar 2026. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97250441
- Mark type
- Stylized text
- Filed
- 02 Feb 2022
- Published for opposition
- 27 Dec 2022
- Abandoned
- 30 Mar 2026
- Attorney of record
- Rachelle A. Dubow, Esq.
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment, prevention and alleviation of gastrointestinal diseases, infections, dysbiosis, and disorders; pharmaceutical preparations for the treatment of metabolic diseases and disorders; Pharmaceuticals, namely, pharmaceutical preparations for gastrointestinal health, gastrointestinal dysbiosis and systemic illnesses associated with gastrointestinal dysbiosis, gastrointestinal disorders and systemic illnesses associated with gastrointestinal disorders, gastrointestinal diseases and systemic illnesses associated with gastrointestinal diseases, gastrointestinal infections and systemic illnesses associated with gastrointestinal infections, used to maintain health and restore health to a human or animal subject via treatment of a disturbed microbial community and prevention of microbial community disruption; Pharmaceutical preparations, namely, preparations for use in the treatment of cancer and tumors; oncolytic viral therapies; biological therapies for use in the treatment of cancer and tumors
Owner
- THERIVA BIOLOGICS, INC, ROCKVILLE, MD, US
- Synthetic Biologics, Inc., Rockville, MD, US
- Synthetic Biologics, Inc., Rockville, MD, US
Prosecution history
- 30 Mar 2026 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 30 Mar 2026 — ABANDONMENT - NO USE STATEMENT FILED
- 30 Mar 2026 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 30 Mar 2026 — ABANDONMENT - NO USE STATEMENT FILED
- 01 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 31 Dec 2025 — SOU EXTENSION 5 GRANTED
- 19 Aug 2025 — SOU EXTENSION 5 FILED
- 31 Dec 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 19 Aug 2025 — SOU TEAS EXTENSION RECEIVED
- 21 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 21 Feb 2025 — SOU EXTENSION 4 GRANTED
- 20 Feb 2025 — SOU EXTENSION 4 FILED
- 20 Feb 2025 — SOU TEAS EXTENSION RECEIVED
- 16 Aug 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Aug 2024 — SOU EXTENSION 3 GRANTED